OrbiMed’s Progyny PGNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-259,900
| Closed | -$7.44M | – | 122 |
|
|
2024
Q2 | $7.44M | Buy |
259,900
+146,600
| +129% | +$4.19M | 0.15% | 80 |
|
|
2024
Q1 | $4.32M | Buy |
+113,300
| New | +$4.32M | 0.08% | 97 |
|
|
2023
Q2 | – | Sell |
-1,037,912
| Closed | -$33.3M | – | 124 |
|
|
2023
Q1 | $33.3M | Buy |
1,037,912
+2,912
| +0.3% | +$93.5K | 0.65% | 49 |
|
|
2022
Q4 | $32.2M | Sell |
1,035,000
-99,053
| -9% | -$3.09M | 0.62% | 56 |
|
|
2022
Q3 | $42K | Buy |
1,134,053
+509,053
| +81% | +$18.9K | 0.78% | 47 |
|
|
2022
Q2 | $18.2K | Buy |
+625,000
| New | +$18.2K | 0.33% | 66 |
|
|
2021
Q4 | – | Sell |
-1,270,045
| Closed | -$71.1M | – | 171 |
|
|
2021
Q3 | $71.1M | Sell |
1,270,045
-95,400
| -7% | -$5.34M | 0.78% | 40 |
|
|
2021
Q2 | $80.6M | Sell |
1,365,445
-559,815
| -29% | -$33M | 0.81% | 40 |
|
|
2021
Q1 | $85.7M | Buy |
1,925,260
+249,760
| +15% | +$11.1M | 0.8% | 37 |
|
|
2020
Q4 | $71M | Hold |
1,675,500
| – | – | 0.62% | 44 |
|
|
2020
Q3 | $49.3M | Buy |
1,675,500
+1,334,496
| +391% | +$39.3M | 0.62% | 48 |
|
|
2020
Q2 | $8.8M | Buy |
+341,004
| New | +$8.8M | 0.12% | 102 |
|